1. Home
  2. THAR vs ASTI Comparison

THAR vs ASTI Comparison

Compare THAR & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • ASTI
  • Stock Information
  • Founded
  • THAR 2017
  • ASTI 2005
  • Country
  • THAR United States
  • ASTI United States
  • Employees
  • THAR N/A
  • ASTI N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • THAR Health Care
  • ASTI Technology
  • Exchange
  • THAR Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • THAR 2.8M
  • ASTI 2.8M
  • IPO Year
  • THAR 2022
  • ASTI N/A
  • Fundamental
  • Price
  • THAR $2.13
  • ASTI $2.87
  • Analyst Decision
  • THAR
  • ASTI
  • Analyst Count
  • THAR 0
  • ASTI 0
  • Target Price
  • THAR N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • THAR 232.7K
  • ASTI 55.4K
  • Earning Date
  • THAR 11-07-2024
  • ASTI 11-14-2024
  • Dividend Yield
  • THAR N/A
  • ASTI N/A
  • EPS Growth
  • THAR N/A
  • ASTI N/A
  • EPS
  • THAR N/A
  • ASTI N/A
  • Revenue
  • THAR N/A
  • ASTI $44,673.00
  • Revenue This Year
  • THAR N/A
  • ASTI N/A
  • Revenue Next Year
  • THAR N/A
  • ASTI N/A
  • P/E Ratio
  • THAR N/A
  • ASTI N/A
  • Revenue Growth
  • THAR N/A
  • ASTI N/A
  • 52 Week Low
  • THAR $1.84
  • ASTI $2.25
  • 52 Week High
  • THAR $8.55
  • ASTI $102.00
  • Technical
  • Relative Strength Index (RSI)
  • THAR 46.63
  • ASTI 57.20
  • Support Level
  • THAR $2.09
  • ASTI $2.47
  • Resistance Level
  • THAR $2.27
  • ASTI $3.15
  • Average True Range (ATR)
  • THAR 0.17
  • ASTI 0.24
  • MACD
  • THAR -0.00
  • ASTI 0.06
  • Stochastic Oscillator
  • THAR 34.04
  • ASTI 69.82

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: